ROCK1, a novel target of miR-145, promotes glioma cell invasion

Molecular Medicine Reports

Volumn 9, Issue 5, 2014, Pages 1877-1882

  Wan, Xin ^a   Cheng, Quan ^a   Peng, Renjun ^a   Ma, Zhiming ^a   Chen, Zigui ^a   Cao, Yiqiang ^a   Jiang, Bing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Glioma; Invasion; microRNA 145; ROCK1; Target

Indexed keywords

GELATINASE A; GELATINASE B; MICRORNA; MICRORNA 145; PROTEIN SERINE THREONINE KINASE; ROCK1 PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA CELL; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION; GLIOMA; HUMANS; MICRORNAS; RHO-ASSOCIATED KINASES; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84899502994     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1982     Document Type: Article

References (31)

1. Wang Y and Jiang T: Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett 331: 139-146, 2013.
2. Nakada M, Kita D, Teng L, et al: Receptor tyrosine kinases: principles and functions in glioma invasion. Adv Exp Med Biol 986: 143-170, 2013.
3. Kwiatkowska A and Symons M: Signaling determinants of glioma cell invasion. Adv Exp Med Biol 986: 121-141, 2013.
4. Nagadia R, Pandit P, Coman WB, Cooper-White J and Punyadeera C: miRNAs in head and neck cancer revisited. Cell Oncol (Dordr) 36: 1-7, 2013.
5. Baer C, Claus R and Plass C: Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res 73: 473-477, 2013.
6. Wang Q, Li P, Li A, et al: Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma. J Exp Clin Cancer Res 31: 97, 2012.
7. Asadi-Moghaddam K, Chiocca EA and Lawler SE: Potential role of miRNAs and their inhibitors in glioma treatment. Expert Rev Anticancer Ther 10: 1753-1762, 2010.
8. Rani SB, Rathod SS, Karthik S, Kaur N, Muzumdar D and Shiras AS: MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro Oncol 15: 1302-1316, 2013.
9. Lu Y, Chopp M, Zheng X, Katakowski M, Buller B and Jiang F: MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells. Oncol Rep 29: 67-72, 2013.
10. Lee SJ, Kim SJ, Seo HH, et al: Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma. Cancer Lett 320: 72-80, 2012.
11. Speranza MC, Frattini V, Pisati F, et al: NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget 3: 723-734, 2012.
12. Chen RH, Wang WJ and Kuo JC: The tumor suppressor DAP-kinase links cell adhesion and cytoskeleton reorganization to cell death regulation. J Biomed Sci 13: 193-199, 2006.
13. 2+ signaling in T cells. Immunol Rev 232: 319-333, 2009.
14. Hall A: Rho family GTPases. Biochem Soc Trans 40: 1378-1382, 2012.
15. Schofield AV and Bernard O: Rho-associated coiled-coil kinase (ROCK) signaling and disease. Crit Rev Biochem Mol Biol 48: 301-316, 2013.
16. Zhou X, Wei M and Wang W: MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. Biochem Biophys Res Commun 437: 653-658, 2013.
17. Bu Q, Tang HM, Tan J, Hu X and Wang DW: Expression of RhoC and ROCK-1 and their effects on MAPK and Akt proteins in prostate carcinoma. Zhonghua Zhong Liu Za Zhi 33: 202-206, 2011 (In Chinese).
18. Majid S, Dar AA, Saini S, et al: MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One 7: e46743, 2012.
19. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005. (Pubitemid 40094598)
20. Oellers P, Schroer U, Senner V, Paulus W and Thanos S: ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons. Glia 57: 499-509, 2009.
21. Inaba N, Ishizawa S, Kimura M, et al: Effect of inhibition of the ROCK isoform on RT2 malignant glioma cells. Anticancer Res 30: 3509-3514, 2010.
22. Hadler-Olsen E, Winberg JO and Uhlin-Hansen L: Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol 34: 2041-2051, 2013.
23. Villadsen SB, Bramsen JB, Ostenfeld MS, et al: The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer 106: 366-374, 2012.
24. Chiyomaru T, Tatarano S, Kawakami K, et al: SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer. Prostate 71: 1559-1567, 2011.
25. Zhang J, Guo H, Zhang H, et al: Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer 117: 86-95, 2011.
26. Lee HK, Bier A, Cazacu S, et al: MicroRNA-145 is down-regulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS One 8: e54652, 2013.
27. Morgan-Fisher M, Wewer UM and Yoneda A: Regulation of ROCK activity in cancer. J Histochem Cytochem 61: 185-198, 2013.
28. Wen S, Shang Z, Zhu S, Chang C and Niu Y: Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells. Prostate 73: 1306-1315, 2013.
29. Wang J, Sun L, Yang M, et al: DEK depletion negatively regulates Rho/ROCK/MLC pathway in non-small cell lung cancer. J Histochem Cytochem 61: 510-521, 2013.
30. Tang AT, Campbell WB and Nithipatikom K: ROCK1 feedback regulation of the upstream small GTPase RhoA. Cell Signal 24: 1375-1380, 2012.
31. Imamura F, Mukai M, Ayaki M and Akedo H: Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase. Jpn J Cancer Res 91: 811-816, 2000.